Literature DB >> 25485009

Preoperative parameters to predict incidental (T1a and T1b) prostate cancer.

Hirofumi Sakamoto1, Kazuhiro Matsumoto1, Nozomi Hayakawa1, Takahiro Maeda1, Atsuko Sato1, Akiharu Ninomiya1, Kiyoshi Mukai2, So Nakamura1.   

Abstract

INTRODUCTON: Prostate cancer has been found incidentally in transurethral resection of the prostate (TURP) specimens without prior diagnosis in 5% to 13% of the patients. We evaluated whether incidental prostate cancer (stages T1a and T1b) could be predicted preoperatively.
METHODS: TURP was performed in 307 patients between 2006 and 2011. Patient age, prostate-specific antigen (PSA) level, total prostate volume, transitional zone volume, PSA density, history of needle biopsy, and pathological diagnosis on TURP specimen were assessed. We analyzed the association between these parameters and prostate cancer detection.
RESULTS: Incidental prostate cancer was found in 31 patients (10.1%), and 13 cases (4.2%) had cancer with T1b and/or Gleason ≥7. Multivariate analysis demonstrated that age ≥75 years (odds ratio [OR] 2.58, p = 0.022), prostate volume ≤50 cc (OR 4.11, p < 0.001), and the absence of preoperative needle biopsy despite PSA ≥4 ng/mL (OR 2.65, p = 0.046) were independent risk factors. In patients who had 2 or 3 of these risk factors, incidental prostate cancer and cancer with T1b and/or Gleason ≥7 were observed in 25% to 50% and 16% to 25% cases, respectively.
CONCLUSIONS: Older patient age, small prostate volume, and the absence of previous needle biopsy (despite a high PSA level) might be independent risk factors for detecting incidental prostate cancer, although external validation is warranted to confirm our results.

Entities:  

Year:  2014        PMID: 25485009      PMCID: PMC4250246          DOI: 10.5489/cuaj.1890

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  21 in total

1.  Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments.

Authors:  M Mazumdar; J R Glassman
Journal:  Stat Med       Date:  2000-01-15       Impact factor: 2.373

2.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial.

Authors:  W J Catalona; A W Partin; K M Slawin; M K Brawer; R C Flanigan; A Patel; J P Richie; J B deKernion; P C Walsh; P T Scardino; P H Lange; E N Subong; R E Parson; G H Gasior; K G Loveland; P C Southwick
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

3.  Photoselective vaporization of the prostate: the basel experience after 108 procedures.

Authors:  Alexander Bachmann; Robin Ruszat; Stephen Wyler; Oliver Reich; Helge H Seifert; Alexander Müller; Tullio Sulser
Journal:  Eur Urol       Date:  2005-03-02       Impact factor: 20.096

4.  Outcome of radical prostatectomy for incidental carcinoma of the prostate.

Authors:  Sebastian Melchior; Boris Hadaschik; Sebastian Thüroff; Christian Thomas; Rolf Gillitzer; Joachim Thüroff
Journal:  BJU Int       Date:  2008-12-08       Impact factor: 5.588

5.  Long-term follow-up of conservatively managed incidental carcinoma of the prostate: a multivariate analysis of prognostic factors.

Authors:  David Robinson; Gunnar Aus; Julia Bak; Tomasz Gorecki; Anders Herder; Johan Rosell; Eberhard Varenhorst
Journal:  Scand J Urol Nephrol       Date:  2007

6.  Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer.

Authors:  M C Benson; I S Whang; A Pantuck; K Ring; S A Kaplan; C A Olsson; W H Cooner
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

7.  Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial.

Authors:  Alexis E Te; Terrence R Malloy; Barry S Stein; James C Ulchaker; Unyime O Nseyo; Mahmood A Hai; Reza S Malek
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

8.  Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up.

Authors:  Moritz F Hamann; Carsten M Naumann; Christof Seif; Christof van der Horst; Klaus-Peter Jünemann; Peter M Braun
Journal:  Eur Urol       Date:  2008-05-16       Impact factor: 20.096

9.  Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

Authors:  William J Catalona; Jerome P Richie; Frederick R Ahmann; M'Liss A Hudson; Peter T Scardino; Robert C Flanigan; Jean B DeKernion; Timothy L Ratliff; Louis R Kavoussi; Bruce L Dalkin; W Bedford Waters; Michael T MacFarlane; Paula C Southwick
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

10.  Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review.

Authors:  Changhee Yoo; Cheol Young Oh; Se Joong Kim; Sun Il Kim; Young Sig Kim; Jong Yeon Park; Do Hwan Seong; Yun Seob Song; Won Jae Yang; Hyun Chul Chung; In Rae Cho; Sung Yong Cho; Sang Hyeon Cheon; Sungjoon Hong; Jin Seon Cho
Journal:  Korean J Urol       Date:  2012-06-19
View more
  6 in total

1.  HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.

Authors:  Bernd Rosenhammer; Eva M Lausenmeyer; Roman Mayr; Maximilian Burger; Christian Eichelberg
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

2.  "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).

Authors:  Annika Herlemann; Kerstin Wegner; Alexander Roosen; Alexander Buchner; Philipp Weinhold; Alexander Bachmann; Christian G Stief; Christian Gratzke; Giuseppe Magistro
Journal:  World J Urol       Date:  2017-05-17       Impact factor: 4.226

3.  Robotic Assisted Laparoscopic Prostatectomy Performed after Previous Suprapubic Prostatectomy.

Authors:  Johnson F Tsui; Michael Feuerstein; Seyed Behzad Jazayeri; David B Samadi
Journal:  Case Rep Med       Date:  2016-11-02

4.  Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study.

Authors:  Zhenlang Guo; Junwei He; Jun Pan; Lijuan Huang; Jiadong Cao; Zunguang Bai; Shusheng Wang; Songtao Xiang; Chiming Gu; Zhaohui Wang
Journal:  Investig Clin Urol       Date:  2022-03

5.  The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?

Authors:  Jens Köllermann; Benedikt Hoeh; Daniel Ruppel; Kevin Smith; Henning Reis; Mike Wenzel; Felix Preisser; Marina Kosiba; Philipp Mandel; Pierre I Karakiewicz; Andreas Becker; Felix K H Chun; Peter Wild; Luis A Kluth
Journal:  Virchows Arch       Date:  2022-06-17       Impact factor: 4.535

6.  Transfer Learning for Adenocarcinoma Classifications in the Transurethral Resection of Prostate Whole-Slide Images.

Authors:  Masayuki Tsuneki; Makoto Abe; Fahdi Kanavati
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.